Finding the Lowest-Cost Pharmacy for Cancer Supportive Care Medications: Not So Easy

被引:8
作者
Etteldorf, Andrew [1 ]
Rotolo, Shannon [2 ]
Sedhom, Ramy [3 ]
Vogel, Rachel, I [1 ]
Blaes, Anne [1 ]
Dusetzina, Stacie B. [4 ]
Virnig, Beth [1 ]
Gupta, Arjun [1 ]
机构
[1] Univ Minnesota, Minneapolis, MN 55455 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1200/OP.22.00051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To decrease the financial burden on people with cancer, clinicians and patients increasingly use medication price comparison websites to seek pharmacies where medications may be cheaper. Shopping around at different pharmacies can add additional time and logistic burden to patients and care partners. We sought to determine whether a single pharmacy consistently offered the lowest price for symptom control medications. METHODS: We compiled medications/formulations used to manage two common cancer-associated symptoms: nausea/vomiting and anorexia/cachexia. We extracted discounted, lowest price with coupon prices for a typical fill of these medications at nine pharmacies in Minneapolis, MN, using GoodRx. We compared prices across formulations and pharmacies to assess whether a pharmacy consistently offered the lowest price. RESULTS: We included 24 formulations for nausea/vomiting (14 generic and 10 brand-name) and 19 for anorexia/cachexia (12 generic and seven brand-name). Prices for brand-name formulations were similar across pharmacies, but prices of generic formulations varied widely across pharmacies. For example, the prices of a seven-unit fill of generic 5-mg olanzapine tablets ranged from $4 to $57 US dollars. No single pharmacy consistently offered the lowest price across the formulations studied. For example, for the 12 generic formulations for anorexia/cachexia, one pharmacy had the highest price for four formulations and the lowest price for two others. CONCLUSION: In this study of discounted medication prices, we found that no single pharmacy in an urban zip code consistently offered the lowest price for medications used to manage two common cancer-associated symptoms. Well-intentioned efforts to pursue the cheapest source of each medication by visiting multiple pharmacies may add extra time and logistic toxicity to patients and care partners. This approach can increase redundant scripts and expose patients to medication-related adverse events.
引用
收藏
页码:596 / +
页数:9
相关论文
共 25 条
[1]   Maximizing Home Time for Persons With Cancer [J].
Banerjee, Rahul ;
George, Manju ;
Gupta, Arjun .
JCO ONCOLOGY PRACTICE, 2021, 17 (09) :513-+
[2]   Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma [J].
Bange, Erin M. ;
Doucette, Abigail ;
Gabriel, Peter E. ;
Porterfield, Florence ;
Harrigan, James J. ;
Wang, Robin ;
Wojcieszynski, Andrzej P. ;
Boursi, Ben ;
Mooney, Bethany I. ;
Reiss, Kim A. ;
Mamtani, Ronac .
JCO ONCOLOGY PRACTICE, 2020, 16 (08) :504-+
[3]   Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment [J].
Brooks, Gabriel A. ;
Landrum, Mary Beth ;
Kapadia, Nirav S. ;
Liu, Pang-Hsiang ;
Wolf, Robert ;
Riedel, Lauren E. ;
Hsu, Van Doren ;
Parekh, Shalini Jhatakia ;
Simon, Carol ;
Hassol, Andrea ;
Keating, Nancy L. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) :1763-+
[4]  
Collins S., 2019, Health insurance coverage eight years after the ACA: Fewer uninsured Americans and shorter coverage gaps, but more underinsured, DOI 10.26099/PENV-Q932
[5]  
Deans E, 2020, USUALLY SEND PEOPLE
[6]  
Dennison Taylor, 2021, J Adv Pract Oncol, V12, P148, DOI 10.6004/jadpro.2021.12.2.3
[7]   Estimated out-of-pocket costs for cancer-directed and supportive care medications for older adults with advanced pancreatic cancer [J].
Desai, Nidhi ;
Besaw, Robert J. ;
Sedhom, Ramy ;
Hussaini, Syed M. Qasim ;
Blaes, Anne H. ;
Dusetzina, Stacie B. ;
Gupta, Arjun .
JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (05) :754-757
[8]   Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents [J].
Doshi, Jalpa A. ;
Li, Pengxiang ;
Huo, Hairong ;
Pettit, Amy R. ;
Armstrong, Katrina A. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) :476-+
[9]  
Gill L.L., 2021, Consumer Reports
[10]  
GoodRx Holdings Inc, 2020, S-1 Registration Statement